Abbott’s trading value on March 5 was $888 million, an increase of 70.51% compared with the previous trading day.

K-LinePoet · 2026-04-07T06:50:18+00:00

On March 5, 2026, Abbott (ABT) stock price fell by 1.82%, with a trading volume of $888 million, a 70.51% increase compared to yesterday. Over the past five trading days and in March, the declines were 4.49% and 4.56%, respectively, and since the beginning of the year, the stock has fallen by 11.37%. The company primarily operates in healthcare products.

K-LinePoet

2026-04-07 06:50:18

Abstract generation in progress

March 5, 2026, medical device company Abbott (ABT) had trading volume of $888.0 million, ranking 157th among U.S. stocks that day. Trading volume increased by 70.51% from the previous day, and the trading volume for the day was 7.9966 million shares.

Abbott (ABT) fell 1.82% on March 5, 2026, to $111.04. Over the past 5 trading days, the stock fell 4.49%; for the entire month of March, it fell 4.56%; year-to-date, it is down 11.37%; and over the past 52 weeks, it fell 19.37%.

*If a company has been listed for less than 52 weeks, then the 52-week percentage change is the percentage change since listing (the same applies to cases where the listing time is less than 1 month or less than 5 trading days)

Abbott (ABT)	Trading value/$	Change in trading value vs. yesterday	Trading volume
March 5, 2026	$888.0 million	70.51%	7.9966 million
March 4, 2026	$521.0 million	-31.61%	4.6139 million
March 3, 2026	$761.0 million	-13.44%	6.7080 million
March 2, 2026	$880.0 million	-42.81%	7.7002 million
February 27, 2026	$1.54B	69.05%	13.2333 million

Abbott is a company based in Illinois, incorporated in 1900. Abbott’s principal business is the discovery, development, manufacture, and sale of a wide variety of healthcare products. The company has four reportable segments: existing pharmaceuticals, diagnostic products, nutrition products, and medical devices.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.